TCI 관리

관리 기준 확인 2/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Yung-Hsiang Lin

최고 경영자

n/a

총 보상

CEO 급여 비율	n/a
CEO 임기	7.5yrs
CEO 소유권	1.2%
경영진 평균 재임 기간	3.5yrs
이사회 평균 재임 기간	5.2yrs

최근 관리 업데이트

Recent updates

CEO

Yung-Hsiang Lin

7.5yrs

테뉴어

Mr. Yung-Hsiang Lin serves as the Chairman, CEO & General Manager of TCI Co., Ltd and has been its Director since May 2017. He holds Bachelor Degree in Botany from National Chung Hsing University. He was a...

리더십 팀

이름	위치	테뉴어	보상	소유권
Yung-Hsiang Lin	Chairman	no data	데이터 없음	1.21% NT$ 177.8m
Chien Tien Huang	Assistant Manager	no data	데이터 없음	데이터 없음
Chen-Chia Huang	Head of Corporate Governance	5.1yrs	데이터 없음	데이터 없음
Wei-Chiang Chi	Head of Audit Department	10.1yrs	데이터 없음	데이터 없음
Tung- Wei Li	US Regional Managing Director	2.7yrs	데이터 없음	데이터 없음
Ching-Ting Chen	Head of Research and Design Center and Institutional Director	4.8yrs	데이터 없음	0.059% NT$ 8.7m
Chiao-Ling Li	Head of Talent Development Center	2.6yrs	데이터 없음	데이터 없음
Hao-Chun Wang	Head of Strategic Intelligence Center	2.6yrs	데이터 없음	데이터 없음
Chiu- Yueh Li	Head of Precise iManufacturing	2.6yrs	데이터 없음	데이터 없음
Juen-Ying Chiou	Head of Stock Service Team	4.3yrs	데이터 없음	데이터 없음

3.5yrs

평균 재임 기간

경험이 풍부한 관리: 8436 의 관리팀은 경험 ( 3.5 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Yung-Hsiang Lin	Chairman	7.5yrs	데이터 없음	1.21% NT$ 177.8m
Ching-Ting Chen	Head of Research and Design Center and Institutional Director	less than a year	데이터 없음	0.059% NT$ 8.7m
Sung-Yuan Liao	Independent Director	7.5yrs	데이터 없음	데이터 없음
Chen-Yi Kao	Independent Director	7.5yrs	데이터 없음	데이터 없음
Pi-Shu Li	Representative Director	5.2yrs	데이터 없음	0.0011% NT$ 164.2k
Shih-Ming Li	Independent Director	4.4yrs	데이터 없음	데이터 없음
Shu-Min He	Independent Director	4.4yrs	데이터 없음	0.00085% NT$ 124.6k

5.2yrs

평균 재임 기간

경험이 풍부한 이사회: 8436 의 이사회는 경험(평균 재직 기간 5.2 년)으로 간주됩니다.

TCI 관리

관리 기준 확인 2/4

주요 정보

최근 관리 업데이트

TCI Co., Ltd. Approves the By-Election of Ching-Ting Chen as Institutional Director

TCI Co., Ltd., Annual General Meeting, Jun 25, 2024

Insufficient new directors

TCI Co., Ltd. Appoints Representative of the Legal Person as Director

TCI Co., Ltd. Announces Executive Changes

TCI Co., Ltd. Appoints Members of the Risk Management Committee

Recent updates

Consensus EPS estimates fall by 20%

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Consensus EPS estimates increase by 13%

TCI Co., Ltd. Unveils Promising GLP-1 Formula Clinical Trial Results for Advanced Weight Management

TCI Co., Ltd. to Report Q2, 2024 Results on Jul 30, 2024

Dividend of NT$7.00 announced

New major risk - Revenue and earnings growth

TCI Co., Ltd. Approves the By-Election of Ching-Ting Chen as Institutional Director

Consensus EPS estimates increase by 16%

First quarter 2024 earnings: EPS exceeds analyst expectations

Now 21% overvalued

TCI Co., Ltd. Board Approves Dividend Distribution for the Year Ended December 31, 2023

TCI Co., Ltd. to Report Q1, 2024 Results on May 09, 2024

TCI Co., Ltd. to Report Q1, 2024 Results on May 09, 2024

Consensus revenue estimates fall by 12%

Full year 2023 earnings: EPS and revenues miss analyst expectations

TCI Co., Ltd., Annual General Meeting, Jun 25, 2024

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

TCI Co., Ltd. Unveils Weight Loss Formula at SupplySide West 2023

Upcoming dividend of NT$5.02 per share at 4.8% yield

TCI Co., Ltd. Announces Cash Dividend, Payable on August 22, 2023

First quarter 2023 earnings: EPS and revenues miss analyst expectations

TCI Introduces Vecollal

TCI Introduces Vecollal

Insufficient new directors

TCI Co., Ltd. Appoints Representative of the Legal Person as Director

Consensus EPS estimates fall by 26%

TCI Co., Ltd. Announces Cash Dividend for the Year Ended December 31, 2022

Now 22% undervalued

Now 20% undervalued

Price target increased by 11% to NT$179

Consensus forecasts updated

Price target increased to NT$177

Investor sentiment improved over the past week

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

TCI Co., Ltd. Announces Executive Changes

Consensus EPS estimates fall by 31%

Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Upcoming dividend of NT$8.92 per share

TCI Co., Ltd. Approves Cash Dividend, Payable on August 18, 2022

Price target decreased to NT$183

TCI Co., Ltd. Appoints Members of the Risk Management Committee

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Now 20% undervalued after recent price drop

Price target decreased to NT$197

TCI Co., Ltd., Annual General Meeting, Jun 29, 2022

Price target decreased to NT$197

Consensus EPS estimates fall by 13%

Price target decreased to NT$258

Price target decreased to NT$278

Price target decreased to NT$283

Third quarter 2021 earnings released: EPS NT$4.02 (vs NT$4.23 in 3Q 2020)

Upcoming dividend of NT$8.88 per share

Second quarter 2021 earnings released: EPS NT$4.19 (vs NT$4.50 in 2Q 2020)

Investor sentiment improved over the past week

TCI Co., Ltd. (TPEX:8436) entered into a memorandum of understanding to acquire US manufacturing operations from NewAge, Inc. (NasdaqCM:NBEV) for $3.5 million.

Head of Finance Department & CFO Chia- Chi Li has left the company

Price target increased to NT$249

Price target increased to NT$240

First quarter 2021 earnings released: EPS NT$3.25 (vs NT$3.13 in 1Q 2020)

Is TCI Co., Ltd. (GTSM:8436) A Smart Choice For Dividend Investors?

Investor sentiment improved over the past week

Full year 2020 earnings released: EPS NT$15.69 (vs NT$17.02 in FY 2019)

Analysts lower EPS estimates to NT$15.17

TCI Co., Ltd. (GTSM:8436) made an offer to acquire 30% stake in Maxigen Biotech Inc. (TSEC:1783) for approximately TWD 600 million.

Price target lowered to NT$235

Full year 2020 earnings released: EPS NT$15.69 (vs NT$17.02 in FY 2019)

Revenue and earnings miss expectations